PORTAL HYPERTENSION

Clinical trials for PORTAL HYPERTENSION explained in plain language.

Never miss a new study

Get alerted when new PORTAL HYPERTENSION trials appear

Sign up with your email to follow new studies for PORTAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 18 Not yet recruiting 12 Not yet finished but already full! 4 Completed 5 Terminated 1

Liver cancer immunotherapy study halted early

Disease control Terminated

This study tested two immunotherapy drugs (durvalumab and tremelimumab) in people with liver cancer who were waiting for a liver transplant. The goal was to see if the drugs could safely shrink tumors and control the disease without causing organ rejection. Only 8 people took par…

Matched conditions: PORTAL HYPERTENSION

Phase: PHASE2 • Sponsor: University of Cincinnati • Aim: Disease control

Last updated Jun 15, 2026 19:04 UTC

PORTAL HYPERTENSION

Get alerted when new PORTAL HYPERTENSION trials appear

Liver cancer immunotherapy study halted early